ask="91.44"
ask_size="500"
average_daily_volume="463434"
bid="N/A"
bid_size="N/A"
book_value="11.49"
change="-0.54"
change_from_200_day_moving_average="15.97"
change_from_50_day_moving_average="12.62"
change_from_52_week_high="-3.64"
change_From_52_week_low="41.19"
change_in_percent="-0.61%"
close="87.71"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-6.21"
ebitda="-244.58M"
eps_estimate_current_year="-7.11"
eps_estimate_next_quarter="-1.78"
eps_estimate_next_year="-6.45"
ex_dividend_date="N/A"
float_shares="38556000"
high="88.67"
high_52_weeks="91.35"
last_trade_date="3/6/2017"
last_trade_price="87.71"
last_trade_size="11751"
last_trade_time="4:00pm"
low="86.43"
low_52_weeks="46.52"
market_capitalization="3.66B"
moving_average_200_day="71.74"
moving_average_50_day="75.09"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="93.71"
open="87.57"
pe_ratio="N/A"
peg_ratio="-0.40"
percent_change_from_200_day_moving_average="+22.26%"
percent_change_from_50_day_moving_average="+16.81%"
percent_change_from_52_week_high="-3.98%"
percent_change_from_52_week_low="+88.54%"
previous_close="88.25"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.68"
price_per_sales="27686.61"
revenue="133000.00"
shares_outstanding="41726000"
short_ratio="13.64"
stock_exchange="NMS"
symbol="RARE"
volume="255117"
weeks_range_52="46.52 - 91.35"
